Publications in collaboration with researchers from Universidad Complutense de Madrid (26)

2022

  1. 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1Receptor for Parkinson's Disease

    Journal of Medicinal Chemistry, Vol. 65, Núm. 18, pp. 12256-12272

  2. Contact lenses for pravastatin delivery to eye segments: Design and in vitro-in vivo correlations

    Journal of Controlled Release, Vol. 348, pp. 431-443

  3. Design, optimization, and in vitro characterization of idebenone-loaded PLGA microspheres for LHON treatment

    International Journal of Pharmaceutics, Vol. 616

  4. Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"

    Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461

  5. Injectable Depot Forming Thermoresponsive Hydrogel for Sustained Intrascleral Delivery of Sunitinib Using Hollow Microneedles

    Journal of Ocular Pharmacology and Therapeutics, Vol. 38, Núm. 6, pp. 433-448

  6. Insights into the Pharmacokinetics and In Vitro Cell‐Based Studies of the Imidazoline I2 Receptor Ligand B06

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  7. Melatonin-Eluting Contact Lenses Effect on Tear Volume: In Vitro and In Vivo Experiments

    Pharmaceutics, Vol. 14, Núm. 5

  8. Phosphorylcholine-Based Contact Lenses for Sustained Release of Resveratrol: Design, Antioxidant and Antimicrobial Performances, and in Vivo Behavior

    ACS Applied Materials and Interfaces, Vol. 14, Núm. 50, pp. 55431-55446

  9. Pluronic®/casein micelles for ophthalmic delivery of resveratrol: In vitro, ex vivo, and in vivo tests

    International Journal of Pharmaceutics, Vol. 628